Scribe Therapeutics Insider Trades
NASDAQ: SCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 9 · $71.34M
- Sales
- 0 · $0
- Shares bought / sold
- 4.73M / 0
- Net activity
- Net buying $71.3 million
Scribe Therapeutics insider activity
Over the last 12 months, Scribe Therapeutics insiders reported 14 transactions on SEC Form 4: 9 open-market purchases and 0 sales. Insiders bought $71.3 million and sold $0 worth of stock, for net insider buying of $71.3 million. The most recent filing shows Aghazadeh Behzad & Avoro Capital Advisors LLC & Avoro Ventures LLC (Director) buying 7,905 shares at $18.25 on Jul 28, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SCTX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SCTX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 28, 2026 | Aghazadeh Behzad & Avoro Capital Advisors LLC & Avoro Ventures LLCDirector | Buy | 7,905 | $144.27K | Form 4 |
| Jul 27, 2026 | Doudna Jennifer A10% Owner | Conversion | 12,511 | — | Form 4 |
| Jul 27, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Buy | 1,000,000 | $15.00M | Form 4 |
| Jul 27, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirector | Conversion | 348,825 | — | Form 4 |
| Jul 27, 2026 | GORDON CARL LDirector | Buy | 1,000,000 | $15.00M | Form 4 |
| Jul 27, 2026 | GORDON CARL LDirector | Conversion | 348,825 | — | Form 4 |
| Jul 27, 2026 | AH Bio Fund II, L.P. & AH Equity Partners Bio II, L.L.C. & AH Bio Fund III, L.P. & AH Equity Partners Bio III, L.L.C. & Andreessen Marc L & HOROWITZ BENJAMIN A10% Owner | Buy | 333,333 | $5.00M | Form 4 |
| Jul 27, 2026 | AH Bio Fund II, L.P. & AH Equity Partners Bio II, L.L.C. & AH Bio Fund III, L.P. & AH Equity Partners Bio III, L.L.C. & Andreessen Marc L & HOROWITZ BENJAMIN A10% Owner | Conversion | 697,650 | — | Form 4 |
| Jul 27, 2026 | AH Bio Fund II, L.P. & AH Equity Partners Bio II, L.L.C. & AH Bio Fund III, L.P. & AH Equity Partners Bio III, L.L.C. & Andreessen Marc L & HOROWITZ BENJAMIN A10% Owner | Conversion | 2,051,742 | — | Form 4 |
| Jul 24, 2026 | Aghazadeh Behzad & Avoro Capital Advisors LLC & Avoro Ventures LLCDirector | Buy | 50,000 | $1.12M | Form 4 |
| Jul 24, 2026 | Aghazadeh Behzad & Avoro Capital Advisors LLC & Avoro Ventures LLCDirector | Buy | 2,333,333 | $35.00M | Form 4 |
| Jul 23, 2026 | Parrot DavidChief Financial Officer | Buy | 1,333 | $20.00K | Form 4 |
| Jul 23, 2026 | Parrot DavidChief Financial Officer | Buy | 1,333 | $20.00K | Form 4 |
| Jul 23, 2026 | Lucas SvetlanaChief Business Officer | Buy | 3,000 | $45.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4